Description:

Serocort Synchrobreathe Inhaler combines two active ingredients to help control and prevent symptoms of asthma and COPD, such as wheezing and shortness of breath. It works by relaxing the muscles in the airways and reducing inflammation, thereby improving breathing.​

Prescription:

This medication requires a prescription from a healthcare provider.​

Therapeutic Category:

Serocort Synchrobreathe belongs to the category of respiratory agents, specifically combination inhalers containing a long-acting beta-agonist (LABA) and an inhaled corticosteroid (ICS).​

Active Ingredients/Composition:

Each actuation of the inhaler delivers:​

• Serocort Synchrobreathe 125:

  • Fluticasone Propionate: 125 mcg​

  • Salmeterol Xinafoate: 25 mcg​

• Serocort Synchrobreathe 250:

  • Fluticasone Propionate: 250 mcg​

  • Salmeterol Xinafoate: 25 mcg

Fluticasone Propionate is a corticosteroid that reduces inflammation in the airways, while Salmeterol Xinafoate is a long-acting bronchodilator that relaxes the muscles around the airways to prevent bronchospasm.​

Vitamins:

This inhaler does not contain any vitamins.​

Minerals:

This inhaler does not contain any minerals.​

Variant:

Serocort Synchrobreathe is available in two dosage strengths:​

• 125 mcg Fluticasone Propionate / 25 mcg Salmeterol Xinafoate​

• 250 mcg Fluticasone Propionate / 25 mcg Salmeterol Xinafoate​

Consume Type:

This medication is for inhalation use only.​

Directions/Usage:

• Preparation: Shake the inhaler well before each use.​

• Inhalation:

  • Exhale fully.​

  • Place the mouthpiece between your lips and form a tight seal.​

  • Inhale deeply and steadily through the mouth while pressing down on the inhaler to release the medication.​

  • Hold your breath for about 10 seconds to allow the medication to reach deep into the lungs.​

  • Exhale slowly.​

• Post-Inhalation: Rinse your mouth with water after each use to minimize the risk of oral thrush.​

The typical dosage is two inhalations twice daily, but follow your healthcare provider’s instructions regarding the specific dose and frequency.​

Common Side Effects: Some users may experience:​

• Headache​

• Throat irritation​

• Hoarseness or voice changes​

• Upper respiratory tract infections​

• Nausea or vomiting​

• Cough​

• Muscle and bone pain​

If any side effects persist or worsen, consult your healthcare provider.​

Package Type:

Serocort Synchrobreathe is supplied as a pressurized inhalation aerosol in a metal canister fitted with a metered-dose valve and an actuator.​

Storage Advice:

• Store at room temperature, away from direct sunlight and moisture.​

• Keep the inhaler out of reach of children and pets.​

• Do not puncture or incinerate the canister, even when empty.​

Safety Advice:

• Not for Acute Attacks:

• This inhaler is not intended for the relief of acute bronchospasm or sudden breathing problems. Use a rescue inhaler for sudden symptoms.​

• Regular Use:

• Use the inhaler regularly as prescribed, even if you feel well, to maintain control over asthma or COPD symptoms.​

• Monitor for Side Effects:

• Be aware of potential side effects, and inform your healthcare provider if they occur.​

• Medical History:

• Inform your doctor of any existing medical conditions, especially heart, liver, or kidney diseases, and any current medications to avoid potential interactions.​

• Pregnancy and Breastfeeding:

• Consult your healthcare provider before using this medication if you are pregnant, planning to become pregnant, or breastfeeding.​

Product Substitutes:

Other combination inhalers containing Fluticasone Propionate and Salmeterol, such as Seroflo Synchrobreathe, may serve as substitutes. Consult your healthcare provider for appropriate alternatives.​

Manufacturer/Marketer:

Serocort Synchrobreathe is manufactured by Cipla Limited, located at Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013, India.​

Country of Origin:

India.